Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Macy's Inc (M) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Macy's Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Macy's Inc trades at $22.62 (market cap $5.94B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Macy's Inc pays a 3.37% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Macy's Inc for 58 Days on average.
| KYMR | M | |
|---|---|---|
Market Cap | $8.87B | $5.94B |
Volume | 779,107 | 4,634,768 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $26.21 |
52-Week Low | $55.80 | $16.92 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $8.26B | $9.73B |
Dividend Yield | — | 3.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Macy's (M) trades at $22.68, down 1.35% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company shows improving fundamentals with Q2 2026 earnings beating estimates and raised full-year guidance, supported by a 'Bold New Chapter' strategy driving digital and omnichannel growth. Valuation ratios remain attractive with a P/E of 8.33 and P/S of 0.27, while cash flow trends have strengthened with net cash flow turning positive in 2025.
The outlook is cautiously optimistic given low valuations and strategic initiatives, but risks include competitive pressures, uneven second-half growth expectations, and macroeconomic sensitivity. Analyst consensus is mixed with a $24.25 price target, implying modest upside, though the stock's 3.5% dividend yield adds income appeal for patient investors amid execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Macy's Inc
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →
